Claim
descriptive

Common blood tests that estimate insulin sensitivity based on fasting glucose and insulin levels are not accurate enough to reliably detect small changes caused by diet, making it hard to trust conclusions based only on these measures.

Evidence from Studies

No evidence studies found yet.

What Would Prove This

Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.

1
Systematic Reviews & Meta-Analyses
In Evidence

Whether surrogate insulin sensitivity indices (e.g., HOMA-IR, Matsuda) consistently underestimate or misclassify small dietary effects compared to the gold standard hyperinsulinemic-euglycemic clamp.

A systematic review comparing 50+ RCTs that measured insulin sensitivity using both surrogate indices and hyperinsulinemic-euglycemic clamp, calculating the correlation and bias between methods across interventions with known effects on insulin sensitivity.

2
Randomized Controlled Trials

Whether a dietary intervention producing a 10% change in insulin sensitivity via clamp is undetected or misclassified by surrogate indices.

A crossover RCT with 40 participants receiving two 6-week diets known to alter insulin sensitivity (e.g., high-fat vs. high-fiber), with insulin sensitivity measured simultaneously by clamp and HOMA-IR/Matsuda index at baseline and end, comparing sensitivity and specificity of each method.

3
Cohort Studies

Whether changes in surrogate insulin sensitivity indices predict future diabetes risk as accurately as clamp-measured changes.

A 10-year prospective cohort of 2,000 adults with annual measurements of both HOMA-IR and clamp-derived insulin sensitivity, analyzing which metric better predicts progression to prediabetes or T2D after adjusting for confounders.

4
Cross-Sectional Studies

Whether surrogate insulin sensitivity indices correlate poorly with clamp measurements in populations with mild insulin resistance.

A cross-sectional study of 300 adults with BMI 25–35 and HOMA-IR 1.8–3.0, measuring insulin sensitivity via both HOMA-IR and clamp, calculating Bland-Altman limits of agreement and Pearson correlation coefficients.

5
Case-Control Studies

Whether individuals classified as insulin resistant by surrogate indices are correctly identified by clamp measurements.

A case-control study comparing 100 individuals classified as insulin resistant by HOMA-IR (>3.0) with 100 controls, all undergoing clamp testing to determine sensitivity and specificity of the surrogate index.

Sign up to see full verdict